A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

NCT03236870 · clinicaltrials.gov ↗
COMPLETED
Status
181
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie